On Ozempic, Wegovy, or Mounjaro? You're Clear to Fly.
GLP-1 weight loss medications are CACI conditions — your AME can issue your medical certificate on the spot. But there's an important distinction between weight loss use and diabetes use.
A CACI Condition for Weight Loss
GLP-1 medications like Ozempic (semaglutide), Wegovy, and Mounjaro (tirzepatide) fall under the CACI pathway when used for weight loss. This means your AME can approve your certificate at the appointment — no FAA deferral needed.
The process typically takes 1 to 2 weeks including getting your documentation together.
The Critical Distinction
The CACI pathway only applies if your GLP-1 is prescribed for weight loss, not diabetes. If your A1C has ever been 6.5% or higher, you follow the diabetes pathway instead — which has different requirements and timelines.
This distinction catches many pilots off guard. Knowing which pathway applies to you before your AME appointment prevents delays.
Get Your Path Confirmed
Our assessment verifies whether your GLP-1 use qualifies for the CACI pathway or the diabetes pathway, and tells you exactly what documentation to bring to your AME appointment.
5 minutes • Instant results